日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The scope and severity of white-nose syndrome on hibernating bats in North America

北美冬眠蝙蝠白鼻综合症的范围和严重程度

Tina L Cheng, Jonathan D Reichard, Jeremy T H Coleman, Theodore J Weller, Wayne E Thogmartin, Brian E Reichert, Alyssa B Bennett, Hugh G Broders, Joshua Campbell, Katherine Etchison, Daniel J Feller, Richard Geboy, Traci Hemberger, Carl Herzog, Alan C Hicks, Sandra Houghton, Jessica Humber, Joseph A

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer

抗PD-1抗体帕博利珠单抗在晚期PD-L1阳性乳头状或滤泡状甲状腺癌患者中的安全性和抗肿瘤活性

Mehnert, Janice M; Varga, Andrea; Brose, Marcia S; Aggarwal, Rahul R; Lin, Chia-Chi; Prawira, Amy; de Braud, Filippo; Tamura, Kenji; Doi, Toshihiko; Piha-Paul, Sarina A; Gilbert, Jill; Saraf, Sanatan; Thanigaimani, Pradeep; Cheng, Jonathan D; Keam, Bhumsuk

Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012

帕博利珠单抗治疗亚太地区晚期头颈部鳞状细胞癌患者:KEYNOTE-012 研究分析

Tahara, Makoto; Muro, Kei; Hasegawa, Yasuhisa; Chung, Hyun Cheol; Lin, Chia-Chi; Keam, Bhumsuk; Takahashi, Kenichi; Cheng, Jonathan D; Bang, Yung-Jue

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

帕博利珠单抗治疗铂类和西妥昔单抗耐药的头颈癌:一项单臂 II 期研究的结果

Bauml, Joshua; Seiwert, Tanguy Y; Pfister, David G; Worden, Francis; Liu, Stephen V; Gilbert, Jill; Saba, Nabil F; Weiss, Jared; Wirth, Lori; Sukari, Ammar; Kang, Hyunseok; Gibson, Michael K; Massarelli, Erminia; Powell, Steven; Meister, Amy; Shu, Xinxin; Cheng, Jonathan D; Haddad, Robert

Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection

局部晚期可切除食管胃癌的诱导治疗:一项采用凡德他尼(ZD6474)、紫杉醇、卡铂、5-氟尿嘧啶和放疗联合手术切除的I期临床试验

Boland, Patrick M; Meyer, Joshua E; Berger, Adam C; Cohen, Steven J; Neuman, Tzahi; Cooper, Harry S; Olszanski, Anthony J; Davey, Monica; Cheng, Jonathan D; Lebenthal, Abraham; Burtness, Barbara A; Scott, Walter J; Astsaturov, Igor A

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

帕博利珠单抗治疗晚期三阴性乳腺癌患者:Ib期KEYNOTE-012研究

Nanda, Rita; Chow, Laura Q M; Dees, E Claire; Berger, Raanan; Gupta, Shilpa; Geva, Ravit; Pusztai, Lajos; Pathiraja, Kumudu; Aktan, Gursel; Cheng, Jonathan D; Karantza, Vassiliki; Buisseret, Laurence

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

帕博利珠单抗在未经生物标志物筛选的复发和/或转移性头颈部鳞状细胞癌患者中的抗肿瘤活性:Ib期KEYNOTE-012扩展队列的结果

Chow, Laura Q M; Haddad, Robert; Gupta, Shilpa; Mahipal, Amit; Mehra, Ranee; Tahara, Makoto; Berger, Raanan; Eder, Joseph Paul; Burtness, Barbara; Lee, Se-Hoon; Keam, Bhumsuk; Kang, Hyunseok; Muro, Kei; Weiss, Jared; Geva, Ravit; Lin, Chia-Chi; Chung, Hyun Cheol; Meister, Amy; Dolled-Filhart, Marisa; Pathiraja, Kumudu; Cheng, Jonathan D; Seiwert, Tanguy Y

Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease

NEMO 的 C 端结构域募集 A20 可抑制 NF-κB 活化和自身炎症疾病

Jevgenia Zilberman-Rudenko, Linda Monaco Shawver, Alex W Wessel, Yongquan Luo, Martin Pelletier, Wanxia Li Tsai, Younglang Lee, Spiridon Vonortas, Laurence Cheng, Jonathan D Ashwell, Jordan S Orange, Richard M Siegel, Eric P Hanson

A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers

一项针对晚期胆道癌患者的蛋白酶体抑制剂硼替佐米的II期临床试验

Denlinger, Crystal S; Meropol, Neal J; Li, Tianyu; Lewis, Nancy L; Engstrom, Paul F; Weiner, Louis M; Cheng, Jonathan D; Alpaugh, R Katherine; Cooper, Harry; Wright, John J; Cohen, Steven J

Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha.

用于成纤维细胞活化蛋白-α体内成像的可激活近红外荧光探针

Li Jinbo, Chen Kai, Liu Hongguang, Cheng Kai, Yang Meng, Zhang Jiping, Cheng Jonathan D, Zhang Yan, Cheng Zhen